GYRE THERAPEUTICS, INC. financial data

Symbol
GYRE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 514% % 51%
Quick Ratio 42% %
Debt-to-equity 26% % -45%
Return On Equity 7.7% % -59%
Return On Assets 6.5% % -55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96,963,611 shares 3.6%
Common Stock, Shares, Outstanding 91,314,007 shares 5.8%
Entity Public Float $72,600,000 USD -13%
Common Stock, Value, Issued $91,000 USD 5.8%
Weighted Average Number of Shares Outstanding, Basic 89,344,622 shares 5%
Weighted Average Number of Shares Outstanding, Diluted 103,180,037 shares 0.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $116,588,000 USD 10%
Research and Development Expense $13,698,000 USD 14%
Selling and Marketing Expense $65,179,000 USD 13%
General and Administrative Expense $20,804,000 USD 29%
Costs and Expenses $105,101,000 USD 17%
Operating Income (Loss) $11,487,000 USD -29%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $14,436,000 USD -38%
Income Tax Expense (Benefit) $4,556,000 USD -14%
Net Income (Loss) Attributable to Parent $9,880,000 USD -45%
Earnings Per Share, Basic 0.06 USD/shares -57%
Earnings Per Share, Diluted 0.02 USD/shares -60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $37,070,000 USD 214%
Accounts Receivable, after Allowance for Credit Loss, Current $31,078,000 USD 59%
Inventory, Net $8,861,000 USD 57%
Other Assets, Current $1,489,000 USD 3.7%
Assets, Current $102,369,000 USD 58%
Deferred Income Tax Assets, Net $6,873,000 USD 22%
Property, Plant and Equipment, Net $23,599,000 USD -1.2%
Operating Lease, Right-of-Use Asset $1,131,000 USD -38%
Other Assets, Noncurrent $2,492,000 USD -18%
Assets $166,132,000 USD 32%
Accounts Payable, Current $124,000 USD 15%
Contract with Customer, Liability, Current $14,000 USD -77%
Liabilities, Current $18,286,000 USD -6.3%
Operating Lease, Liability, Noncurrent $303,000 USD -66%
Other Liabilities, Noncurrent $1,448,000 USD 20586%
Liabilities $23,850,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $779,000 USD 70%
Retained Earnings (Accumulated Deficit) $68,426,000 USD 6.8%
Stockholders' Equity Attributable to Parent $106,031,000 USD 67%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $142,282,000 USD 45%
Liabilities and Equity $166,132,000 USD 32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $129,000 USD -104%
Net Cash Provided by (Used in) Financing Activities $1,344,000 USD 104%
Net Cash Provided by (Used in) Investing Activities $1,967,000 USD
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 91,314,007 shares 5.8%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,232,000 USD
Deferred Tax Assets, Valuation Allowance $70,148,000 USD 6.9%
Deferred Tax Assets, Gross $77,414,000 USD 8.1%
Operating Lease, Liability $939,000 USD -41%
Payments to Acquire Property, Plant, and Equipment $122,000 USD -47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $6,845,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid $971,000 USD -43%
Property, Plant and Equipment, Gross $31,175,000 USD 5.8%
Operating Lease, Liability, Current $636,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $303,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year One $668,000 USD -15%
Operating Lease, Weighted Average Discount Rate, Percent 0.0476 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32,000 USD -66%
Lessee, Operating Lease, Liability, to be Paid, Year Three $279,000 USD 163%
Deferred Tax Assets, Operating Loss Carryforwards $42,239,000 USD 1.3%
Unrecognized Tax Benefits $1,883,000 USD 0%
Operating Lease, Payments $47,000 USD -66%
Additional Paid in Capital $172,047,000 USD 26%
Amortization of Intangible Assets $576,000 USD 1416%
Depreciation, Depletion and Amortization $535,000 USD 29%
Deferred Tax Assets, Net of Valuation Allowance $6,873,000 USD 22%
Share-based Payment Arrangement, Expense $7,157,000 USD 761%